Physician

Alysa Robin Herman, MD

According to 2025 Medicare claims, Alysa Herman, MD (NPI: 1245235829) practices micrographic dermatologic surgery in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is ALYSA R. HERMAN, MD, PA (NPI: 1669293122; TIN: 261399413) and primary practice location at 33416-1876.

Herman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 704 traditional Medicare patients, billed 4,313 HCPCS/CPT codes, and received $881,664 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 133 prescription claims across 94 beneficiaries totaling $2,413 in drug costs, led by Fluorouracil (Fluorouracil). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $7,371 to $2,413. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$497K$994K2015 Medicare payment: $637,558 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $638,312 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $897,365 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $928,022 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $994,221 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $831,556 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $909,047 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $760,394 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $868,391 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $881,664 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155483,566$637,558
20165703,428$638,312
20177144,898$897,365
20187465,024$928,022
20197905,314$994,221
20206834,662$831,556
20217764,785$909,047
20227614,046$760,394
20237934,450$868,391
20247044,313$881,664

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.7K$7.4K2015 Drug cost: $7,371 (USD; Tot_Drug_Cst)2016 Drug cost: $3,938 (USD; Tot_Drug_Cst)2017 Drug cost: $3,577 (USD; Tot_Drug_Cst)2018 Drug cost: $4,330 (USD; Tot_Drug_Cst)2019 Drug cost: $2,404 (USD; Tot_Drug_Cst)2020 Drug cost: $1,619 (USD; Tot_Drug_Cst)2021 Drug cost: $2,509 (USD; Tot_Drug_Cst)2022 Drug cost: $2,882 (USD; Tot_Drug_Cst)2023 Drug cost: $3,585 (USD; Tot_Drug_Cst)2024 Drug cost: $2,413 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201569106$7,371
201674110$3,938
201798154$3,577
201876121$4,330
201970107$2,404
20205994$1,619
202176111$2,509
202276112$2,882
202397148$3,585
202494133$2,413

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks373521$510
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks265522$342
11102Biopsy of related skin growth, first growth222330$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more229306$64
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more191263$44

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil13375$715
CefdinirCefdinir40200$586
Acetaminophen-CodeineAcetaminophen With Codeine1654$77
Ciprofloxacin HclCiprofloxacin Hcl1381$75
Triamcinolone AcetonideTriamcinolone Acetonide11280$56

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Alysa Robin Herman, MD?

Tedicare shows public-source Medicare data for Alysa Robin Herman, MD (NPI 1245235829), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alysa Robin Herman, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alysa Robin Herman, MD?

Alysa Robin Herman, MD is linked to ALYSA R. HERMAN, MD, PA (billing NPI 1669293122) in the available physician profile data.

Does Alysa Robin Herman, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.